InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Pourhassan Nader, Chairman & CEO. Insider active across 1 company, notably CytoDyn Inc.. Cumulatively, 2 disclosures have been recorded. Activity tracked since 6 August 2021. The latest transaction was filed on 6 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Nader Pourhassan is President and CEO of CytoDyn Inc. He leads the company with a focus on innovation and the development of new therapies. His leadership is essential to CytoDyn's mission.